<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Danaher Corporation — News on 6ix</title>
<link>https://6ix.com/company/danaher-corporation</link>
<description>Latest news and press releases for Danaher Corporation on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 23 Apr 2026 21:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/danaher-corporation" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68355dc278dffbe2df0ece4a.webp</url>
<title>Danaher Corporation</title>
<link>https://6ix.com/company/danaher-corporation</link>
</image>
<item>
<title>Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer</title>
<link>https://6ix.com/company/danaher-corporation/news/avantorr-announces-ludovic-brellier-as-executive-vice-president-bioscience-and-medtech-products-bmp-and-chief-transformation-officer-1</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/avantorr-announces-ludovic-brellier-as-executive-vice-president-bioscience-and-medtech-products-bmp-and-chief-transformation-officer-1</guid>
<pubDate>Thu, 23 Apr 2026 21:05:00 GMT</pubDate>
<description>Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Ludovic Brellier will join the company as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer on May 1, 2026.</description>
</item>
<item>
<title>Danaher Announces Pricing of Euro-Denominated Senior Notes Offering</title>
<link>https://6ix.com/company/danaher-corporation/news/danaher-announces-pricing-of-euro-denominated-senior-notes-offering</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/danaher-announces-pricing-of-euro-denominated-senior-notes-offering</guid>
<pubDate>Wed, 22 Apr 2026 23:15:00 GMT</pubDate>
<description>Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced an offering of the following euro-denominated senior notes (the "Offering"):</description>
</item>
<item>
<title>Danaher Reports First Quarter 2026 Results</title>
<link>https://6ix.com/company/danaher-corporation/news/danaher-reports-first-quarter-2026-results</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/danaher-reports-first-quarter-2026-results</guid>
<pubDate>Tue, 21 Apr 2026 10:00:00 GMT</pubDate>
<description>Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2026. All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted.</description>
</item>
<item>
<title>Cepheid and Oxford Nanopore Expand Partnership Following Successful Phase One Collaboration</title>
<link>https://6ix.com/company/danaher-corporation/news/cepheid-and-oxford-nanopore-expand-partnership-following-successful-phase-one-collaboration</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/cepheid-and-oxford-nanopore-expand-partnership-following-successful-phase-one-collaboration</guid>
<pubDate>Wed, 15 Apr 2026 07:00:00 GMT</pubDate>
<description>Cepheid, a Danaher company and a leader in molecular diagnostics for infectious diseases, and Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology for real-time genomic analysis, today announced an expansion of their partnership to develop a workflow for rapid bacterial and fungal pathogen identification. Following a successful phase one collaboration announced at the European Society of Clinical Microbiology and Infectious Diseases</description>
</item>
<item>
<title>Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes</title>
<link>https://6ix.com/company/danaher-corporation/news/beckman-coulter-diagnostics-earns-ce-mark-for-new-assay-delivering-bacterial-vs-viral-infection-results-in-approximately-20-minutes</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/beckman-coulter-diagnostics-earns-ce-mark-for-new-assay-delivering-bacterial-vs-viral-infection-results-in-approximately-20-minutes</guid>
<pubDate>Mon, 13 Apr 2026 07:01:00 GMT</pubDate>
<description>Beckman Coulter Diagnostics, a Danaher company and global leader in clinical diagnostics, today announced it has received CE 2797 mark under IVDR for the Access MeMed BV assay, enabling broad availability of a high-throughput host‑response test that helps clinicians differentiate between bacterial and viral infections in approximately 20 minutes.</description>
</item>
<item>
<title>Leica Biosystems Solidifies Leadership in Digital Pathology with Launch of Next-Generation Aperio GT Elite Scanner and Aperio iQC Software</title>
<link>https://6ix.com/company/danaher-corporation/news/leica-biosystems-solidifies-leadership-in-digital-pathology-with-launch-of-next-generation-aperio-gt-elite-scanner-and-aperio-iqc-software</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/leica-biosystems-solidifies-leadership-in-digital-pathology-with-launch-of-next-generation-aperio-gt-elite-scanner-and-aperio-iqc-software</guid>
<pubDate>Mon, 23 Mar 2026 16:00:00 GMT</pubDate>
<description>Leica Biosystems, a Danaher Company and a global leader in anatomic pathology solutions, continues to enhance digital pathology workflows with the US launch of the Aperio GT EliteTM scanner, along with Aperio iQC software incorporating unique rescan functionality. Together, these next-generation innovations deliver unmatched speed, intelligence, and workflow certainty to help accelerate slide processing and review while advancing cancer research for improved outcomes.</description>
</item>
<item>
<title>Danaher Schedules First Quarter 2026 Earnings Conference Call</title>
<link>https://6ix.com/company/danaher-corporation/news/danaher-schedules-first-quarter-2026-earnings-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/danaher-schedules-first-quarter-2026-earnings-conference-call</guid>
<pubDate>Fri, 20 Mar 2026 20:15:00 GMT</pubDate>
<description>Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2026 on Tuesday, April 21, 2026 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations.</description>
</item>
<item>
<title>IDBS Wins Best Biologics Digitalisation: Software Innovation Award, at the 2026 Asia Pacific Biopharma Excellence Awards</title>
<link>https://6ix.com/company/danaher-corporation/news/idbs-wins-best-biologics-digitalisation-software-innovation-award-at-the-2026-asia-pacific-biopharma-excellence-awards</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/idbs-wins-best-biologics-digitalisation-software-innovation-award-at-the-2026-asia-pacific-biopharma-excellence-awards</guid>
<pubDate>Thu, 12 Mar 2026 15:14:00 GMT</pubDate>
<description>IDBS, a leading provider of cloud software for biopharma companies and a Danaher company, is proud to announce that it has been awarded the Best Biologics Digitalisation: Software Innovation Award, at the Asia Pacific Biopharma Excellence Awards (ABEA) 2026. This prestigious recognition highlights IDBS' outstanding contributions to enabling digital transformation and advancing biopharma excellence in the Asia-Pacific region.</description>
</item>
<item>
<title>mAbxience Selects Genedata Bioprocess to Automate End-to-End CDMO Workflows</title>
<link>https://6ix.com/company/danaher-corporation/news/mabxience-selects-genedata-bioprocess-to-automate-end-to-end-cdmo-workflows</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/mabxience-selects-genedata-bioprocess-to-automate-end-to-end-cdmo-workflows</guid>
<pubDate>Tue, 10 Mar 2026 12:30:00 GMT</pubDate>
<description>Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that mAbxience has selected the Genedata Bioprocess® enterprise platform to structure and harmonize all bioprocess development data across its operations. mAbxience, majority-owned by the Fresenius Kabi group, is a global Contract Development and Manufacturing Organization (CDMO) specializing in the manufacture of biosimilars.</description>
</item>
<item>
<title>Beckman Coulter Diagnostics Selects Innovaccer Gravity™ as AI and Data Platform for Clinical Laboratory Operations Modernization</title>
<link>https://6ix.com/company/danaher-corporation/news/beckman-coulter-diagnostics-selects-innovaccer-gravitytm-as-ai-and-data-platform-for-clinical-laboratory-operations-modernization</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/beckman-coulter-diagnostics-selects-innovaccer-gravitytm-as-ai-and-data-platform-for-clinical-laboratory-operations-modernization</guid>
<pubDate>Mon, 09 Mar 2026 13:00:00 GMT</pubDate>
<description>SAN FRANCISCO, March 09, 2026--Innovaccer Inc., a leading healthcare AI company, today announced that Beckman Coulter Diagnostics, a global clinical diagnostics leader and a Danaher company, has selected Gravity, Innovaccer’s enterprise data and AI platform, to support its vision for modernizing and scaling customers’ clinical laboratory operations.</description>
</item>
<item>
<title>Pall Corporation Appoints Dr. Roland Folz as President</title>
<link>https://6ix.com/company/danaher-corporation/news/pall-corporation-appoints-dr-roland-folz-as-president</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/pall-corporation-appoints-dr-roland-folz-as-president</guid>
<pubDate>Tue, 03 Mar 2026 13:00:00 GMT</pubDate>
<description>Pall Corporation, a Danaher company and a global leader in filtration, separation and purification, announced the appointment of Dr. Roland Folz as President, Pall Corporation, effective March 3, 2026.</description>
</item>
<item>
<title>Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer</title>
<link>https://6ix.com/company/danaher-corporation/news/quest-diagnostics-names-benjamin-beauvalot-senior-vice-president-chief-strategy-and-manda-officer-1</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/quest-diagnostics-names-benjamin-beauvalot-senior-vice-president-chief-strategy-and-manda-officer-1</guid>
<pubDate>Thu, 26 Feb 2026 13:24:00 GMT</pubDate>
<description>Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that Benjamin Beauvalot, a highly accomplished leader with more than two decades of experience in business strategy and transformation, including mergers and acquisitions (M&A), has joined the company as senior vice president, chief strategy and M&A officer.</description>
</item>
<item>
<title>Danaher To Acquire Masimo Corporation</title>
<link>https://6ix.com/company/danaher-corporation/news/danaher-to-acquire-masimo-corporation-1</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/danaher-to-acquire-masimo-corporation-1</guid>
<pubDate>Tue, 17 Feb 2026 13:00:00 GMT</pubDate>
<description>Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: MASI) a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings. Under the terms of the agreement, Danaher will acquire all of the outstanding shares of Masimo common stock for $180 per share in cash, or a total enterprise value of approximately $</description>
</item>
<item>
<title>Automata Raises $45M Series C to Build the Operating System for AI-Ready Labs</title>
<link>https://6ix.com/company/danaher-corporation/news/automata-raises-dollar45m-series-c-to-build-the-operating-system-for-ai-ready-labs</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/automata-raises-dollar45m-series-c-to-build-the-operating-system-for-ai-ready-labs</guid>
<pubDate>Thu, 29 Jan 2026 14:00:00 GMT</pubDate>
<description>LONDON, January 29, 2026--Automata, the lab automation company building fully integrated, AI-ready platforms for life sciences, today announced the close of a $45 million Series C funding round led by Dimension with participation from Danaher Ventures, Tru Arrow Partners, Octopus Ventures, Entrepreneurs First, and others. The round also includes a strategic investment partnership with Danaher Corporation, with Murali Venkatesan Ph.D., Global Head of Danaher Ventures and Vice President of Science</description>
</item>
<item>
<title>Danaher Reports Fourth Quarter and Full Year 2025 Results</title>
<link>https://6ix.com/company/danaher-corporation/news/danaher-reports-fourth-quarter-full-110000895</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/danaher-reports-fourth-quarter-full-110000895</guid>
<pubDate>Wed, 28 Jan 2026 11:00:00 GMT</pubDate>
<description>Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2025. All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted.</description>
</item>
<item>
<title>Danaher CEO to Comment on Financial Performance</title>
<link>https://6ix.com/company/danaher-corporation/news/danaher-ceo-financial-performance-140000787</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/danaher-ceo-financial-performance-140000787</guid>
<pubDate>Mon, 12 Jan 2026 14:00:00 GMT</pubDate>
<description>Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company's fourth quarter 2025 performance in a presentation at the J.P. Morgan Healthcare Conference at 11:15 a.m. PT.</description>
</item>
<item>
<title>Danaher to Present at J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/danaher-corporation/news/danaher-present-j-p-morgan-211500162</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/danaher-present-j-p-morgan-211500162</guid>
<pubDate>Mon, 05 Jan 2026 21:15:00 GMT</pubDate>
<description>Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 13, 2026 at 11:15 a.m. PT. The event will be simultaneously webcast and can be accessed on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations."</description>
</item>
<item>
<title>Danaher Schedules Fourth Quarter 2025 Earnings Conference Call</title>
<link>https://6ix.com/company/danaher-corporation/news/danaher-schedules-fourth-quarter-2025-123000664</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/danaher-schedules-fourth-quarter-2025-123000664</guid>
<pubDate>Wed, 17 Dec 2025 12:30:00 GMT</pubDate>
<description>Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2025 on Wednesday, January 28, 2026 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations.</description>
</item>
<item>
<title>Indicor Announces Leadership Transition</title>
<link>https://6ix.com/company/danaher-corporation/news/indicor-announces-leadership-transition</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/indicor-announces-leadership-transition</guid>
<pubDate>Tue, 16 Dec 2025 12:05:00 GMT</pubDate>
<description>Indicor, LLC ("Indicor" or "the Company") announced today that Doug Wright is stepping down as Chief Executive Officer and from the Company's Board of Directors. Mr. Wright will become CEO of ATS Corporation, a publicly-listed company headquartered in Canada that builds automation systems for a range of product categories. John Stroup, Chairman of Indicor, will serve as interim CEO effective immediately.</description>
</item>
<item>
<title>Danaher Announces Quarterly Dividend</title>
<link>https://6ix.com/company/danaher-corporation/news/danaher-announces-quarterly-dividend-211500317</link>
<guid isPermaLink="true">https://6ix.com/company/danaher-corporation/news/danaher-announces-quarterly-dividend-211500317</guid>
<pubDate>Tue, 09 Dec 2025 21:15:00 GMT</pubDate>
<description>Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on January 30, 2026 to holders of record on December 26, 2025.</description>
</item>
</channel>
</rss>